Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Yasuda H, Ichihara E, Sakakibara-Konishi J, Zenke Y, et al. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung Cancer 2021;162:140-146.
PMID: 34808485


Privacy Policy